Financhill
Back

Penumbra Quote, Financials, Valuation and Earnings

Penumbra Price Quote

$242.15
-0.39 (-0.56%)
(Updated: December 21, 2024 at 5:41 AM ET)

Penumbra Key Stats

Buy
74
Penumbra (PEN) is a Buy

Day range:
$241.24 - $245.89
52-week range:
$148.00 - $277.34
Dividend yield:
0%
P/E ratio:
104.54
P/S ratio:
8.16
P/B ratio:
8.43%

Volume:
864.4K
Avg. volume:
325.7K
1-year change:
-1.81%
Market cap:
$9.3B
Revenue:
$1.1B
EPS:
$0.86

How Much Does Penumbra Make?

Data Unavailable

Is Penumbra Growing As A Company?

Data Unavailable

Penumbra Stock Price Performance

  • Did Penumbra Stock Go Up Last Month?
    Penumbra share price went up by 1.4% last month
  • Did PEN's Share Price Rise Over The Last Year?
    PEN share price fell by -1.81% over the past 1 year

What Is Penumbra 52-Week High & Low?

  • What Is Penumbra’s 52-Week High Share Price?
    Penumbra has traded as high as $277.34 over the past 52 weeks
  • What Is Penumbra’s 52-Week Low Share Price?
    Penumbra has traded as low as $148.00 over the past 52 weeks

Penumbra Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Penumbra?

Data Unavailable

Is Penumbra Cash Flow Positive?

Data Unavailable

Penumbra Return On Invested Capital

Data Unavailable

Penumbra Earnings Date & Stock Price

  • What Is Penumbra's Stock Price Today?
    A single share of PEN can be purchased today for 242.54
  • What Is Penumbra’s Stock Symbol?
    Penumbra trades on the nyse under the ticker symbol: PEN
  • When Is Penumbra’s Next Earnings Date?
    The next quarterly earnings date for Penumbra is scheduled on February 21, 2025
  • When Is PEN's next ex-dividend date?
    Penumbra's next ex-dividend date is May 27, 2020
  • How To Buy Penumbra Stock?
    You can buy Penumbra shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Penumbra Competitors

  • Who Are Penumbra's Competitors?
    Below is a list of companies who compete with Penumbra or are related in some way:
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Inari Medical Inc (NARI)
    • QuidelOrtho Corp (QDEL)
    • ResMed Inc (RMD)

Penumbra Dividend Yield

Data Unavailable

Penumbra Analyst Estimates

YoY Growth Past Surprise
EPS: 226.09% 23.7%
Revenue: 11.11% 1.23%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 259.40
Upside from Last Price: 6.95%

Major Shareholders

Data Unavailable